Atlas Trials

Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis

Clinical trial NCT02497976 · COMPLETED

Trial details

NCT number
NCT02497976
Sponsor
ICStudy, LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Cystitis, Interstitial
Start date
2015-12-15
Primary completion
2017-04-16
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.